Get startedLog in
    Picture of Genmab A/S logo

    GMAB — Genmab A/S News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Genmab Revises 2026 Adjusted Operating Profit Guidance To $1.07 Billion To$1.39 Billion

    Picture of Genmab A/S logoGenmab A/S
    06/08/2026 16:06
    BRIEF-Genmab Revises 2026 Adjusted Operating Profit Guidance To $1.07 Billion To$1.39 Billion
    Aug 6 (Reuters) - Genmab A/S GMAB.CO:
    • GENMAB ANNOUNCES FINANCIAL RESULTS FOR THE FIRST HALF OF 2026
    • GENMAB - NET SALES OF DARZALEX BY J&J $8.17 BILLION FOR FIRST SIX MONTHS OF 2026, UP 21%
    • GENMAB - ADJUSTED OPERATING PROFIT $656 MILLION FOR FIRST SIX MONTHS OF 2026
    • GENMAB - REVISES 2026 REVENUE GUIDANCE TO $4,325 MILLION-$4,525 MILLION
    • GENMAB - REVISES 2026 ADJUSTED OPERATING PROFIT GUIDANCE TO $1.07 BILLION - $1.39 BILLION
    Source text: ID:nGNXcf87vn
    Further company coverage: GMAB.CO

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Genmab A/S

    See all news